How the use of M&S in cancer trials from the outset can help address those critical “what if?” scenarios and accelerate oncology drug development.
Marc Pfister, MD, FCP
Advertisement
Articles by Marc Pfister, MD, FCP
Advertisement
Latest Updated Articles
Leveraging Modeling & Simulation in OncologyPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
